Recent Advances in Molecular Mechanisms of Cancer Immunotherapy
Cancers · 11.05.2023 · 15 (10) · 2721
DOI: 10.3390/cancers15102721 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Cancers, online erschienen am 11.05.2023. Verfasst von Mateusz Kciuk und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Molecular Biotechnology and Genetics, University of Lodz, Banacha Street 12/16, 90-237 Lodz, Poland. Die Arbeit wurde bisher 122-mal zitiert (Crossref) und nennt 216 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: the Deanship of Scientific Research at King Khalid University, King Khalid University, University of Lodz.
Abstract (Originalsprache)
Cancer is among the current leading causes of death worldwide, despite the novel advances that have been made toward its treatment, it is still considered a major public health concern. Considering both the serious impact of cancer on public health and the significant side effects and complications of conventional therapeutic options, the current strategies towards targeted cancer therapy must be enhanced to avoid undesired toxicity. Cancer immunotherapy has become preferable among researchers in recent years compared to conventional therapeutic options, such as chemotherapy, surgery, and radiotherapy. The understanding of how to control immune checkpoints, develop therapeutic cancer vaccines, genetically modify immune cells as well as enhance the activation of antitumor immune response led to the development of novel cancer treatments. In this review, we address recent advances in cancer immunotherapy molecular mechanisms. Different immunotherapeutic approaches are critically discussed, focusing on the challenges, potential risks, and prospects involving their use.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Molecular Biotechnology and Genetics, University of Lodz, Banacha Street 12/16, 90-237 Lodz, Poland.
- Doctoral School of Exact and Natural Sciences, University of Lodz, Banacha Street 12/16, 90-237 Lodz, Poland.
- Bioprocess Technology Division, School of Industrial Technology, Universiti Sains Malaysia, Penang 11800, Malaysia.
- Faculty of Applied Medical Sciences, Mohail Aseer, King Khalid University, Abha 62529, Saudi Arabia.
- Department of Pharmacology & Toxicology, College of Pharmacy, Prince Sattam bin Abdulaziz University, Al-Kharj 11942, Saudi Arabia.
- Shandong Provincial Key Laboratory of Glycoscience and Glycoengineering, School of Medicine and Pharmacy, Ocean University of China, Qingdao 266003, China.
ORCID-Profile: Mateusz Kciuk, Esam Bashir Yahya, Muhammad Omer Iqbal, Renata Kontek
Förderung
- the Deanship of Scientific Research at King Khalid University
- King Khalid University
- University of Lodz
Zitieren
APA
Kciuk, M., Yahya, E. B., Mohamed Ibrahim Mohamed, M., Rashid, S., Iqbal, M. O., Kontek, R., Abdulsamad, M. A., & Allaq, A. A. (2023). Recent Advances in Molecular Mechanisms of Cancer Immunotherapy. Cancers, 15(10), 2721. https://doi.org/10.3390/cancers15102721
Vancouver
Kciuk M, Yahya EB, Mohamed Ibrahim Mohamed M, Rashid S, Iqbal MO, Kontek R, et al. Recent Advances in Molecular Mechanisms of Cancer Immunotherapy. Cancers. 2023;15(10):2721. doi:10.3390/cancers15102721
BibTeX
@article{Kciuk2023,
author = {Kciuk, Mateusz and Yahya, Esam Bashir and Mohamed Ibrahim Mohamed, Montaha and Rashid, Summya and Iqbal, Muhammad Omer and Kontek, Renata and Abdulsamad, Muhanad A and Allaq, Abdulmutalib A},
title = {Recent Advances in Molecular Mechanisms of Cancer Immunotherapy},
journal = {Cancers},
year = {2023},
volume = {15},
number = {10},
pages = {2721},
doi = {10.3390/cancers15102721}
}
EUVIMED